Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: Feasibility study with rodents

Radiology

Volumn 226, Issue 2, 2003, Pages 465-473

  Yang, David J ^a   Kim, Chang Guhn ^a   Schechter, Naomi R ^a   Azhdarinia, Ali ^a   Yu, Dong Fang ^a   Oh, Chang Sok ^a   Bryant, Jerry L ^a   Won, Jong Jin ^a   Kim, E Edmund ^a   Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Contrast media, experimental studies; Experimental study; Neoplasms, experimental studies; Radionuclide imaging, experimental studies

Indexed keywords

CYANAMIDE; CYSTEINE DERIVATIVE; ETHYLENEDICYSTEINE; ETHYLENEDICYSTEINE DEOXYGLUCOSE TC 99M; FLUORODEOXYGLUCOSE F 18; GLUCOSAMINE; GLUCOSE; HEXOKINASE; INSULIN; TECHNETIUM 99M; UNCLASSIFIED DRUG; (99M)TC ETHYLENEDICYSTEINE DEOXYGLUCOSE; (99M)TC ETHYLENEDICYSTEINE-DEOXYGLUCOSE; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CONTROLLED STUDY; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HINDLIMB; HUMAN; LUNG TUMOR; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RODENT; SCINTIGRAPHY; TUMOR CELL CULTURE; ANIMAL; DRUG EFFECT; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; BLOOD GLUCOSE; CYSTEINE; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; INSULIN; LUNG NEOPLASMS; MICE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; TISSUE DISTRIBUTION;

EID: 0037289634     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2262011811     Document Type: Article

References (35)

1. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30:150-185.
2. Plowman PN, Saunders CA, Maisey M. On the usefulness of brain PET scanning to the pediatric neuro-oncologist. Br J Neurosurg 1997; 11:525-532.
3. Weber WA, Avril N, Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkl 1999; 175:356-373.
4. Lau CL, Harpole DH, Patz E. Staging techniques for lung cancer. Chest Surg Clin N Am 2000; 10:781-801.
5. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumor like lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695-1701.
6. Yutani K, Shiba E, Kusuoka H, et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000; 24:274-280.
7. Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumors: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27:1305-1311.
8. Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000; 6:1279-1287.
9. Meyer PT, Spetzger U, Mueller HD, Zeggel T, Sabri O, Schreckenberger M. High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case report. Clin Nucl Med 2000; 25: 694-697.
10. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881.
11. Carretta A, Landoni C, Melloni G, et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases: a pilot study. Eur J Cardiothorac Surg 2000; 17:377-383.
12. Torre W, Garcia-Velloso MJ, Galbis J, Fernandez O, Richter J. FDG-PET detection of primary lung cancer in a patient with an isolated cerebral metastasis. J Cardiovasc Surg 2000; 41:503-505.
13. Brunelle F. Noninvasive diagnosis of brain tumors in children. Childs Nerv Syst 2000; 16:731-734.
14. Mankoff DA, Dehdashti F, Shields AF. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia 2000; 2:71-88.
15. Fitzgerald J, Parker JA, Danias PG. F-18 fluorodeoxyglucose SPECT for assessment of myocardial viability. J Nucl Cardiol 2000; 7:382-387.
16. Schwarz A, Kuwert T. Nuclear medicine diagnosis in diseases of the central nervous system. Radiology 2000; 40:858-862.
17. Roelcke U, Leenders KL. PET in neurooncology. J Cancer Res Clin Oncol 2001; 127:2-8.
18. 18F-fluorodeoxyglucose metabolic imaging of tumors benefit oncology? Eur J Nucl Med 1997; 24:691-705.
19. Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med 1999; 26:1251-1258.
20. 99mTc annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116:844-853.
21. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993; 20:738-746.
22. Canet EP, Casali C, Desenfant A, et al. Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRI. Magn Reson Med 2000; 43: 403-409.
23. Laissy JP, Faraggi M, Lebtahi R, et al. Functional evaluation of normal and ischemic kidney by means of gadolinium-DOTA enhanced TurboFLASH MR imaging: a preliminary comparison with 99Tc-MAG3 dynamic scintigraphy. Magn Reson Imaging 1994; 12:413-419.
24. Kao CH, ChangLai SP, Chieng PU, et al. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response: a preliminary report. Cancer 1998; 83:64-68.
25. Blondeau P, Berse C, Gravel D. Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid. Can J Chem 1967; 45:49-52.
26. Ratner S, Clarke HT. The action of formaldehyde upon cysteine. J Am Chem Soc 1937; 59:200-206.
27. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent: synthesis, labeling and evaluation in animals. Cancer Biother Radiopharm 1998; 13:427-435.
28. 99mTc-ethylenedicysteine-colchicine for evaluation of antiangiogenic effects. Anticancer Drugs 1999; 10: 685-692.
29. 99mTc-labeled metronidazole. Pharm Res 1999; 16:743-750.
30. 99mTc-EC-annexin V. Cancer Biother Radiopharm 2001; 16:73-84.
31. Xie W, van de Werve G, Berteloot A. An integrated view of the kinetics of glucose and phosphate transport, and of glucose 6-phosphate transport and hydrolysis in intact rat liver microsomes. J Membr Biol 2001; 179:113-126.
32. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNac. Science 2001; 291:2376-2378.
33. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J Biol Chem 1991; 266:4706-4712.
34. Gaudreault N, Santure M, Pitre M, Nadeau A, Marette A, Bachelard H. Effects of insulin on regional blood flow and glucose uptake in Wistar and Sprague-Dawley rats. Metabolism 2001; 50:65-73.
35. Fallavollita JA. Spatial heterogeneity in fasting and insulin-stimulated (18)F-2-deoxyglucose uptake in pigs with hibernating myocardium. Circulation 2000; 102: 908-914.